drugset / Trial / NCT01841086

Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation

NCT01841086

Phase 1 Completed 50 enrolled Korea United Pharm. Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the pharmacokinetics of sarpogrelate controlled-release formulation (CR) in comparison to immediate-release formulation (IR) and Food effect on the pharmacokinetics of sarpogrelate CR.

Timeline

Start
2011-09
Primary completion
2011-11
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sarpogrelate Small molecule 100 mg
Subject Sarpogrelate Small molecule 300 mg

Indications

No indication recorded.